Formulation and Evaluation of Niosomal Gel of Antifungal Luliconazole
Abstract
Niosomes have potential applications in topical drug delivery system. Niosomes play an increasingly important role in drug delivery as they can reduce toxicity and modify pharmacokinetic and bio-availability. Topically applied niosomes can increase the residence time of drugs in the stratum corneum and epidermis, while reducing the systemic absorption of the drug. It can act as drug containing reservoirs and the modification of the vesicular compositions or surface properties can adjust the drug release rate and the affinity for the target site. Luliconazole is a potential prescription candidate drug for the treatment of topical fungal infections. However, it has water solubility and skin permeability limitations. To overcome these limitations, a niosomal gel of luliconazole was formulated using Span 60, cholesterol and chloroform to improve its bioavailability and to reduce its toxicity. Niosomes were analyzed by transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FTIR) for morphological and spectral studies respectively. The formulations had ideal nanometric vesicle sizes, encapsulation efficiency (88.891% ± 0.0364%), Zeta potential (-40.1 mV), and storage instability was not observed. The sustained-release profile of niosomal gel was observed for up to 24 h. The highest R2 value was 0.913; the Higuchi model was considered the best fit model for the niosomal formulations. Based on the results, it can be concluded that niosomal luliconazole may enhance the activity of luliconazole against Candida albicans.
Keywords: Luliconazole, Niosomes, Transdermal drug delivery, Antifungal drugs, Candida albicans
Keywords:
Luliconazole, Niosomes, Transdermal drug delivery, Antifungal drugs, Candida albicansDOI
https://doi.org/10.22270/jddt.v12i6-S.5705References
Gupta A, Singh S, Kotla NG, et al. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine. 2014; 10:171-182. https://doi.org/10.2147/IJN.S70449
Gorain B, Choudhury H, Pandey M, et al. Dendrimers as effective carriers for the treatment of brain tumor. In: Prashant Kesharwani, Umesh Gupta, editors. Nanotechnology-based targeted drug delivery systems for brain tumors. Academic Press; 2018. p. 267-305. https://doi.org/10.1016/B978-0-12-812218-1.00010-5
Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm. 2011; 403:245-253. https://doi.org/10.1016/j.ijpharm.2010.10.027
Mishra V, Kesharwani Nkj P. Functionalized polymeric nanoparticles for delivery of bioactives. Nanobiomedicine, Publisher M/s Studium Press LLC, USA, 2014.
Kesharwani P, Banerjee S, Gupta U, et al. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics. Mater Today. 2015; 18(10):565-572. https://doi.org/10.1016/j.mattod.2015.06.003
Manosroi A, Wongtrakul P, Manosroi J, et al. The entrapment of kojic oleate in bilayer vesicles. Int J Pharm. 2005; 298:13-25. https://doi.org/10.1016/j.ijpharm.2005.02.041
Uttam KK, Prashant K, Suresh Kumar G, et al. Development and characterization of chitosan nanoparticles and improvement of oral bioavailability of poorly water soluble acyclovir. Res J Pharm Technol. 2010; 3(4):1241-1245.
Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases-estimate precision. JoF. 2017; 3(4):57. https://doi.org/10.3390/jof3040057
Kim JY. Human fungal pathogens: why should we learn? J Microbiol. 2016; 54(3):145-148. https://doi.org/10.1007/s12275-016-0647-8
Khanna D, Bharti S. Luliconazole for the treatment of fungal infections: an evidence based review. Core Evid. 2014; 9:113-24. https://doi.org/10.2147/CE.S49629
Ghanghoria R, Kesharwani P, Agashe HB, et al. Transdermal delivery of cyclodextrin solubilized curcumin. Drug Deliv Transl Res. 2013; 3(3):242-285. https://doi.org/10.1007/s13346-012-0114-y
Pandey M, Choudhury H, Yeun OC, et al. Perspectives of nanoemulsion strategies in the improvement of oral, parenteral and transdermal chemotherapy. Curr Pharm Biotechnol. 2018; 19(4):276-292. https://doi.org/10.2174/1389201019666180605125234
Kaul S, Yadav S, Dogra S. Treatment of dermatophytosis in elderly, children, and pregnant women. Indian Dermatol Online J. 2017; 8(5):310. https://doi.org/10.4103/idoj.IDOJ_169_17
Lewis RE. Current concepts in antifungal pharmacology. Mayo Clin Proc. 2011; 86(8):805-817. https://doi.org/10.4065/mcp.2011.0247
Zhang L, Pornpattananangku D, Hu C-MJ, et al. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem. 2010; 17(6):585-594. https://doi.org/10.2174/092986710790416290
Ashley ESD, Lewis R, Lewis JS, et al. Pharmacology of systemic antifungal agents. Clin Infect Dis. 2006; 43:S28-S39. https://doi.org/10.1086/504492
Tripathi PK, Gorain B, Choudhury H, et al. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. Heliyon. 2019; 5(3):e01343. https://doi.org/10.1016/j.heliyon.2019.e01343
Madheswaran T, Baskaran R, Yoo BK, et al. In vitro and in vivo skin distribution of 5a-reductase inhibitors loaded into liquid crystalline nanoparticles. J Pharm Sci. 2017; 106(11):3385-3394. https://doi.org/10.1016/j.xphs.2017.06.016
Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008; 361(1-2):104-111. https://doi.org/10.1016/j.ijpharm.2008.05.031
Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. Int J Pharm Sci Res. 2013; 4(5):1782.
Patel AN, Rai JP, Jain DK, Banweer JI. Formulation, development and evaluation of cefaclor extended release matrix tablet. Int J Pharm Pharm Sci. 2012; 4(4):355-7.
Jain P, Nair S, Jain N, Jain DK, Jain S. Formulation and evaluation of solid dispersion of lomefloxacin hydrochloride. Int J Res Pharm Sci 2012; 3(4):604-608.
Barakat HS, Darwish IA, El-Khordagui LK, et al. Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm. 2009; 35:631-637. https://doi.org/10.1080/03639040802498864
Kumbhar D, Wavikar P, Vavia P. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS PharmSciTech. 2013; 14(3):1072-1082. https://doi.org/10.1208/s12249-013-9986-5
Herrera LC, Tesoriero MVD, Hermida LG. In vitro release testing of PLGA microspheres with Franz diffusion cells. Dissolution Technol. 2012; 19(2):6-11. https://doi.org/10.14227/DT190212P6
Kumar A, Transferosome: A recent approach for transdermal drug delivery, Journal of Drug Delivery and Therapeutics. 2018; 8(5-s):100-104 https://doi.org/10.22270/jddt.v8i5-s.1981
Singh S, Kotla NG, Tomar S, et al. Ananomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil. Int J Nanomedicine. 2015; 10:7175-7182. https://doi.org/10.2147/IJN.S89030
Kurakula MC, Srinivas, Kasturi N, Diwan PV. Formulation and Evaluation of Prednisolone Proliposomal Gel for Effective Topical Pharmacotherapy. International Journal of Pharmaceutical Sciences and Drug Research, 2012; 4(1):35-43.
Published
Abstract Display: 1308 
PDF Downloads: 1015 PDF Downloads: 714 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.